drugset / Trial / NCT00553865

Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets

NCT00553865 ↗

Phase 2 Completed 120 enrolled Jeil Pharmaceutical Co., Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the optimal dosage of the clinical trial which is evaluating the antihypertensive efficacy and the safety of OJP-2028 tablets in patients with the uncomplicated essential hypertension.

Timeline

Start
2007-11
Primary completion
2008-10
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject OJP-2028 Unknown 1 mg —
Subject OJP-2028 Unknown 2 mg —
Subject OJP-2028 Unknown 4 mg —